Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Lymphogranuloma venereum and chancroid

Essential points for quick revision.

Saved on this device
!
Severe proctitis or suppurating nodes

Systemic illness, bowel obstruction, severe rectal bleeding, peritonism, rapidly enlarging fluctuant nodes or genital ulceration with sepsis can represent complicated invasive infection or another surgical process.

Action: Assess haemodynamic status and acute abdomen, obtain rectal or ulcer specimens and blood tests, start specialist-directed therapy without waiting when disease is severe, and involve colorectal surgery or acute care for obstruction, perforation or uncontrolled suppuration.

Synopsis

Distinguish invasive lymphogranuloma venereum from chancroid and other genital-ulcer syndromes, obtain specialist testing, and apply pathogen-specific regimens, follow-up and partner lookbacks.

  • LGV is invasive infection with C. trachomatis L1–L3: transient ulcer may be missed, followed by painful nodes or proctocolitis with rectal pain, bleeding, discharge and tenesmus.
  • Chancroid causes one or more painful soft genital ulcers with ragged undermined edges and tender regional lymphadenitis; it is rare in the UK and usually linked to travel or an outbreak.
  • Test LGV with chlamydia NAAT from the symptomatic rectal, ulcer or node site followed by LGV genotyping; a routine negative genital sample does not exclude rectal disease.

Key red flags

Severe anorectal pain, bleeding, tenesmus, fever or abdominal tenderness requires urgent assessment for LGV proctocolitis and inflammatory or surgical mimics.

A fluctuant inguinal bubo can rupture and form a sinus; arrange aspiration or specialist drainage while continuing effective antibiotics.

Neurological, ocular or cardiovascular features require syphilis assessment and cannot be attributed to a local ulcer syndrome.

Pregnancy changes prolonged tetracycline and fluoroquinolone choices and requires specialist infection and maternity advice.

Persistent ulceration after therapy raises herpes, syphilis, mpox, malignancy, resistant H. ducreyi or an incorrect diagnosis.

Complicated invasive disease

Severe bleeding, abdominal distension, obstruction, fistula, peritonism or sepsis requires urgent specialist and surgical assessment.

Investigation priorities

01
Site-specific chlamydia NAAT with LGV genotypingFirst step

Detect C. trachomatis at the affected rectal, ulcer or nodal site and identify invasive L genovars.

Management branches

DISTINGUISHInvestigate ulcer or proctitis by site

A patient has painful genital ulceration, inguinal nodes, proctitis or an epidemiological link to LGV or chancroid.

  1. Record exposure sites, timing, travel, outbreak contact, pain, rectal bleeding, bowel change, systemic symptoms, pregnancy and prior antibiotics.
  2. Examine skin, oral and genital sites, rectum when appropriate, and inguinal nodes, looking for fluctuance, obstruction and another acute abdomen.

Key medicines

Doxycycline for LGVTake 100 mg orally twice daily for twenty-one days for symptomatic lymphogranuloma venereum.Review pregnancy, oesophagitis, photosensitivity and interacting cations; seek specialist advice for alternatives and ensure contacts receive equal duration.
Ceftriaxone for chancroidGive 250 mg by intramuscular injection as a single dose for confirmed uncomplicated chancroid.Check severe beta-lactam allergy, confirm the diagnosis where possible, and review healing because large ulcers or HIV-associated disease may respond slowly.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 13 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom